Fusion of TLS/FUS and CHOP gene by reciprocal translocation t(12;16)(q32;q16) is a common genetic event found in myxoid and round-cell liposarcomas. Characterization of this genetic event was performed by three methods, Southern blot, RT ± PCR, and genomic long-distance PCR in nine myxoid and three round-cell liposarcomas. All but one tumors showed genetic alternations indicating the fusion of TLS/FUS and CHOP gene. Two novel types of fusion transcripts were found, of which one lacked exon 2 sequence of CHOP gene, and the other lacked 3' half of exon 5 of TLS gene. The latter case was caused by a cryptic splicing site which was created by the genomic fusion. Detailed analyses genomic fusion points revealed several sequence characteristics surrounding the fusion points. Homology analyses of breakpoint sequences with known sequence motifs possibly involve in the process of translocation uncovered Translin binding sequences at both of TLS/ FUS and CHOP breakpoints in two cases. Translocations were always associated with other genetic alterations, such as deletions, duplications, or insertions. Short direct repeats were almost always found at both ends of deleted or duplicated fragments some of which had apparently been created by joining of sequences that ank the rearrangement. Finally, consensus topoisomerase II cleavage sites were found at breakpoints in all cases analysed, suggesting a role of this enzyme in creating staggered ends at the breakpoint. These data suggested that sequence characteristics may play an important role to recruit several factors such as Translin and topoisomerase II in the process of chromosomal translation in liposarcomas.
Introduction
One of the frequent genetic alterations found in human malignant tumors is a special recurrent chromosomal translocation . Structural analyses of fusion genes have revealed two major types of recombination events. One is that the fusion of the regulatory part of one gene to the entire coding region of the other gene, resulting in abnormally regulated expression of the latter. Translocation of the coding region of the c-myc gene to the regulatory region of joining or diversity segments of immunoglobulin in Burkitt's lymphoma is a prototype of this rearrangement (Taub et al., 1982) . The second type of translocation caused the breaks to occur within the coding region of two genes creating a fusion gene that encodes a chimeric protein. The fusion of the BCR and c-ABL genes on the Philadelphia chromosome in chronic myelogenous leukemia typi®es this class of rearrangement (De Klein et al., 1982) . Recent investigations in solid tumors, especially sarcomas, have led to the identi®cation of such speci®c chimeric proteins in several types of tumors . The genes involved in this type of rearrangement frequently encode potential transcription factors and nucleic acid-binding proteins . These fusion proteins are postulated to have an eector domain form one translocation partner and the nucleic acid-binding domain of the other, resulting in a neomorphic mutant protein that contributes to tumorigenesis.
The translocation t(12;16) in liposarcomas produces a product by fusing a gene on chromosome 16 called TLS (or FUS) and a gene encoding a transcription factor called CHOP on chromosome 12 (Crozat et al., 1993; Rabbitts et al., 1993) . The TLS/FUS (hereafter called simply TLS) product contains a glutamineserine-tyrosine-rich segment, three glycin-rich stretches and a RNA-binding domain (Crozat et al., 1993; Rabbitts et al., 1993) . The wild type CHOP product possesses a leucine zipper dimerization domain, and the protein forms complexes with the members of the CCAAT/enhancer-binding protein family of transcription factors (C/EBP). The association of CHOP with C/EBPs blocks their ability to bind classical C/EBP target genes and directs the heteromeric complex type novel sites (Ron and Habener, 1992; Ubeda et al., 1996) . Both the DNA-binding and leucine zipper dimerization motif of CHOP are retained after the translocation, and the TLS domain in the fusion protein provides a transcriptional activator function (Sanchez-Garcia and Rabbitts, 1994; Zinszner et al., 1994) . This type of mutation was initially found in myxoid liposarcomas (MLS), which is the most common subtype of liposarcomas (Crozat et al., 1993; Rabbitts et al., 1993) , and afterwards in round cell liposarcomas (RCLS) (Knight et al., 1995) . Mutations in TLS or CHOP were not found in other types of liposarcomas, nor in other sarcomas with myxoid changes, such as myxoid malignant ®brous histiocytomas (Nilbert et al., 1995) . Several studies concerning the TLS-CHOP rearrangements in MLS and RCLS have shown that there are two major (types I and II) and one rare (type III) types of fusion transcripts caused by dierent locations of breakpoints in each of TLS and CHOP gene (Panagopoulos et al., 1994; Kuroda et al., 1995) . The identi®cation of rare types of transcripts will be important in terms of what they tell us about the minimal structural requirements for oncogenicity. A related issue is whether the predominance of major transcripts in clinical samples is caused by features of the genomic structure around the breakpoints which may enhance the incidence of certain types of recombination events. Until recently, detailed analysis of breakpoints sequence required the laborious constructing of genomic libraries from each tumor samples and the cloning of the breakpoint (Heistelkamp et al., 1985) . Therefore, in spite of numerous descriptions of chromosomal translocations, relatively few breakpoints have been characterized at the molecular level. Recent progress in PCR-based technology, however, has made it possible to amplify long genomic fragments encompassing the genomic breakpoint (Cheng et al., 1994; Panagopoulos et al., 1996a) .
In this study, we performed the detailed characterization of TLS-CHOP translocation in MLS and RCLS by Southern blotting, reverse transcription (RT) ± PCR, and long-distance genomic PCR. Evidence for the implication of speci®c sequence motifs in the chromosomal translocation was uncovered.
Results

Gross rearrangements in the CHOP locus
Initial analysis was performed by the hybridization of BamHI digested genomic DNA to a CHOP cDNA probe. Germline DNA showed a single band with a size of 8.5 kb, whereas ten of 12 tumors showed and additional band with a dierent size (representative cases were shown in Figure 1 ). The two cases with a normal pattern in BamHI digested DNA showed an extra band in Southern blotting analysis using SacI digested DNA (data not shown). These extra bands were not observed in the analysis of DNA form peripheral white blood cells (WBCs) of each patients excluding the possibilities of RFLP (data not shown). Therefore, all of nine MLS and three RCLS were found to have a rearrangement in the CHOP locus.
Gross rearrangements in the TLS/FUS locus
Among 12 tumors, eight tumors shown an additional band in the analysis of PstI digested genomic DNA hybridized with a TLS cDNA probe (representative cases were shown in Figure 2 ). These include seven out of nine MLS and one of three RCLS. 
Detection of fusion transcripts
RNA was available in six/nine MLS and three/three RCLS, and b-actin transcripts could be ampli®ed from RT products in all of these (data not shown). RT products of each sample was ampli®ed with a sense primer in exon 4 of TLS gene (294F) and an antisense primer in exon 3 of CHOP gene (176R). Fusion transcripts were detected in eight/nine cases, the exception being case KS307, in which no rearrangement was detected in the TLS locus by Southern blotting. RT ± PCR products of other eight cases were recovered from agarose gel, puri®ed, cloned and sequenced. There were four kinds of fusion transcripts with a size of 635 bp (three cases), 377 bp (three cases) 329 bp (one case), and 284 bp (one case) (representative cases were shown in Figure 3 ). Sequence analysis revealed that the longest fragment consisted of exons 4 ± 7 of TLS and exons 2 ± 3 of CHOP. The fragment next in size (377 bp) consisted of exons 4 ± 5 of TLS and exons 2 ± 3 of CHOP (Figure 4 ). These two fusion transcripts are identical to the two types of fusion transcripts previously described (types I and II) (Panagopoulos et al., 1995) . The 329 bp fragment, tentatively designated as type IV, was found to consist of exons 4 ± 5 of TLS and exon 3 of CHOP (Figure 4 ). This fusion resulted in a glycine to alanin substitution at codon 169 of TLS, and the junction between TLS and authentic CHOP was made up of ten amino acids encoded by 5' portion of exon 3 of CHOP gene. The shortest fragment, tentatively designed as type V, consisted of 5' part of exon 5 of TLS and exons 2 ± 3 of CHOP (Figure 4 ). In this fusion transcript, the exon 5 sequence of TLS was interrupted at the third nucleotide of codon 144 and after this point exon 2 sequence of CHOP gene was found. This fusion resulted in a glycine to valine substitution at codon 144 of TLS. In addition, 26 amino acids at the junction of TLS and CHOP are encoded by exon 2 and the 5' normally non-coding portion of exon 3 of CHOP gene. Among the four cases with no apparent abnormality in the TLS locus by Southern blotting, one case (KS374) showed a type II fusion and one case (KS180) showed a type V fusion transcript. Of the other cases, KS307 failed to show a fusion transcript as mentioned above and RNA was not available in the last case (KS227).
Genomic breakpoint analysis
Normal intron sequence of the CHOP locus The length of introns 1 and 2 were 2 658 bp and 352 bp, respectively. Because the size of intron 1 was signi®cantly dierent from the data in the original description (Park et al., 1992) , we ampli®ed this intron from ten dierent individuals, with identical results. Our measurements of the intron size are furthermore consistent with recently published results (Panagopoulos et al., 1997) . Computer analysis showed that two regions in intron 1 were homologous with a consensus Alu sequence (Kariya et al., 1987) . There are no sequences in these region homologous to the consensus KpnI sequence. (Crowther et al., 1991) . No apparent repetitious regions such as microsatellite were found, and no direct or inverted repeat region was found.
Breakpoints of TLS/FUS and CHOP gen in TLS/FUS-CHOP fusion genome
The TLS-CHOP genomic fusion fragments were successfully ampli®ed in 11 of 12 cases, the exception bing KS307 in which no rearrangement of TLS was detected by Southern blot analysis and no RT ± PCR product was obtained in the analysis or TLS-CHOP fusion transcript (representative cases were shown in Figure 5 ). Ten of these 11 genomic fragments were cloned and sequenced, the exception being KS386, in which we were unable to clone the fragment probably due to a poor yield of the ampli®cation product. Breakpoints of the TLS gene were found to be in intron 5 in six cases, intron 7 in three cases, and in the middle of exon 5 in one case ( Figure 6a ). Among six breakpoints in intron 5 of the TLS gene, three were found in Alu sequence (Figure 6a ). In the case of CHOP gene, breakpoints of seven were in intron 1 (Figure 6b ). There are two Alu regions in this intron as mentions above, but none of seven breakpoints in intron 1 were in Alu sequence (Figure 6b ). Two cases were found to have a breakpoint at approximately 1 kb upstream from the transcription starting site of CHOP. There is an Alu region close to these breakpoints, and in one of them the breakpoint was in Alu region. Interestingly, this is the only case in which both of TLS and CHOP breakpoints occurred in Alu sequence. The breakpoint in the tenth case was in intron 2 of CHOP. Computer analyses revealed that the breakpoints in two cases (KS387 and KS410) had a strong homology with the consensus recognition sequences of a recombination hotspot binding protein, Translin (Aoki et al., 1995) (Table 1) . Interestingly, homology was found at the breakpoint of both of TLS and CHOP locus in both cases (Table 1) .
Relationship between the location of breakpoints and the structure of fusion transcripts
In all of three cases with type I fusion transcript, TLS breakpoints were in intron 7, and CHOP breakpoints were in intron 1, consistent with the structure of the fusion transcript (Table 2 ). In two cases with a type II fusion transcript, the breakpoints in TLS were in intron 5, and those in CHOP gene were in intron 1 (Table 2) , which is also consistent with the structure of the fusion transcript. In the third case with a type II transcript, the TLS breakpoint was in intron 5, but the breakpoint of the CHOP locus was found to be in the promoter region (upstream of exon 1). However, exon 1 of CHOP was not incorporated in the fusion mRNA. This may be due to the lack of canonical spliceacceptor site at the 5' of exon 1 of the CHOP gene. In KS509 with a type IV transcript, the breakpoint of TLS gene was in intron 5 and that of CHOP was in The TLS-CHOP fusion genome in this case contained an 101 bp insertion at the fusion point, of which the origin was unknown TLS-CHOP breakpoint sequences in liposarcomas H Kanoe et al intron 2, resulting in the absence of CHOP exon 2 sequence in the fusion transcript of this case ( Table 2) . The genomic breakpoint in the case with a type V fusion transcript (KS180) was particularly novel (Figure 7 ). The normal sequence around the breakpoint in exon 5 was ATGG/AC, which was converted to ATGG/TA by the fusion with the CHOP sequence derived from approximately 1 kb upstream form exon 1. The new genomic sequence at the fusion point is predicated to be able serve as a splice donor site and because of the lack of an appropriate splicing acceptor site at 5' of exon 1 of CHOP, truncated exon 5 of TLS was united with exon 2 of the CHOP gene resulting in an in-frame fusion.
Genomic alteration associated with translocations
To de®ne these changes in detail the sequence of both CHOP-TLS fusion fragments and TLS-CHOP fragments should be determined. Of ten cases in which the TLS-CHOP fusion could be evaluated six provided useful information on the reciprocal product, CHOP-TLS. There was no case with a simple end-to-end reciprocal translocation. All cases were found to have additional genomic alterations such as deletions, duplications, or insertions, Due to homologies or mutations at the breakpoints, it is impossible to arrive at a single interpretation of the molecular event, and therefore in each case described below, one of several possible interpretations is schematically presented. In three cases, the associated genomic alteration was a deletion. In KS287 (Figure 7a ), 23 bp sequence of TLS and 25 bp sequence of CHOP gene were deleted from the fusion gene. Both the TLS and CHOP deleted sequences had a short direct repeat (TTC) at their ends. In both the TLS and CHOP locus, the sequence around deleted fragments were found to have a high degree of similarity to consensus topoisomerase II cleavage sites (89% and 82% respectively). In KS410 (Figure 7b ), 56 bp was deleted from the original TLS locus. There were no apparent direct repeat sequences at the end of deleted fragment. However, there was CACCT sequence at the 5' end of deleted TLS fragment, and exactly the same 5 bp sequence derived form the CHOP gene was found at the fusion point. Therefore, if the fusion gene initially created by translocation without deletion, the deleted sequence would have been lodged between two CACCT sequences, one form TLS and the other from CHOP. Sequence homology with consensus topoisomerase II cleavage site (78%) was again found at the end of deleted fragment. Similar, but not exactly same process may be considered in the case of KS427 (Figure 7c ). That case is associated with a GATT deletion of the CHOP sequence and although there is no apparent repeat sequences in the germline CHOP gene adjacent to this deleted sequence, genomic fusion with the TLS breakpoint would result in the placement of CTTT and CTT sequence at the both sides of deleted GATT stretch. This GATT region was found to be the end of sequences homologous to consensus topoisomerase II cleavage sites (78%).
There was one case with a duplication (Figure 7d ). In KS374, 12 ± 14 bp of TLS gene adjacent to the breakpoint was duplicated, and no additional change was found in the CHOP gene. No apparent short direct repeat was found at the ends of duplicated fragment. Homology with consensus topoisomerase II cleavage sites was again found at the breakpoint of this case (76%), and the duplicated fragment was almost totally included in consensus sequences.
The structures of the remaining two cases were much more complicated, and both shared several common features. In KS373 (Figure 7e ), the mutation consisted of 29 bp deletion and 14 bp insertion in the TLS gene. The deleted fragments again had a short direct repeat (ACATT) at the both ends of fragment, and sequences around the 3' end of the deleted fragment matched the consensus topoisomerase II cleavage site (100%). The origin of inserted sequence remains unknown, but it is identical with the complementary sequence of TLS gene starting form 89 bp upstream of the breakpoint. The mutation of the last case, KS376, was further complicated (Figure 7f ). There was a 446 bp duplication of the TLS gene, and 44 bp deletion and 86 bp insertion of he CHOP gene. The 3' end of the duplicated region was in a stretch of Ts and the 5' end was in an Alu sequence 6 bp from poly (T) stretch of the Alu repeat. The deleted fragment had a TGGG sequence around both ends and the 5' end of this fragments showed a homology with the consensus topoisomerase II cleavage site (83%). The origin of inserted fragments was also complementary to a sequence of the CHOP gene starting 16 bp downstream and ending at 70 bp upstream from the breakpoint.
Discussion
Among 12 tumors analysed in this study, one tumor (KS307) failed to show any evidence for a TLS-CHOP translocation, although a rearrangement of the CHOP gene was evident by Southern blot. It is possible that this tumor had a TLS-CHOP translocation which could not be detected by the methods used in this study. An alternative explanation would be that the translocation partner of CHOP gene in this case was not TLS but another gene, such as EWS (Panagopoulos et al., 1996b) . In the other 11 tumors, we could detect at least one genetic alternation indicating the presence of TLS-CHOP translocation.
Two novel forms of fusion transcripts (types IV and V) were found in this study and further analysis of the encoded protein will hopefully provide new information on the regions of TLS and CHOP genes required to create oncogenic fusion proteins. Type IV transcripts in KS509 lacked exon 2 sequences of the CHOP gene. Although this exon is`non-coding' in the germline CHOP, the presence of polypeptide derived from this sequence has been found in all cases of TLS-CHOP described to date. This raised the possibility that this polypeptide may play some role in the transforming ability of TLS-CHOP. The data presented here suggested that in fact exon 2 sequence may be dispensable for oncogenicity of TLS-CHOP. The second novel transcript (type V), found in KS180, lacked the 3' portion of exon 5 of TLS. The TLS part in the type V transcript is the shortest among those in ®ve types of TLS-CHOP fusion transcripts. It will be interesting to compare the oncogenic activities of these rare TLS-CHOP fusion proteins with those of more common types (Kuroda et al., 1997) .
Although there are numerous instances of chromosomal translocations in human malignancies, the mechanism underlying this type of genetic alteration is still unclear. It is likely that the driving force in creating the observed chromosomal translocation is not the chromatin feature of the implicated genes but rather the resulting altered genotypes that endow cells with selective advantages. For example, the fusion of exon 6 of TLS and exon 2 of CHOP would result in a frame shift mutation in CHOP coding region, and this will be the reason why no breakpoints were found in intron 6 of the TLS gene. However, within the constraint imposed by the need to encode a fusion oncoprotein, the distribution of breakpoints in the two genes suggests that certain features of DNA and chromatin structure may also have impact on the process of translocation. One myxoid liposarcoma case was reported in which the fusion transcript contained exon 8 sequence, suggesting that the entire region of intron 8 will be a target for the breakpoint (Kuroda et al., 1995) . However, combining the data of our analysis and those in the previous report (Panagopoulos et al., 1995) , the locations of breakpoints of the TLS locus were intron 5 in 14 cases, intron 7 in eight cases, and none were found in intron 8. This distribution was apparently not proportional to the size of introns (531 bp, 1489 bp, and 765 bp, respectively). If there are no signi®cant dierence in the oncogenic activity of fusion proteins encoded by these dierent fusion oncogenes our data suggest that there are some particular sequences which make genomic DNA predisposed to translocations. The presence of Alu region in intron 5 of the TLS gene suggested that the unequal distribution of breakpoints may relate to this repetitious sequence. The Alu sequences, however, may not play a major role in determining the location of the breakpoints, because none of seven breakpoints in CHOP intron 1 were found in Alu sequences, and the frequency of breakpoints in Alu sequence in intron 5 of TLS locus (3/6=0.5) was equal to the ratio of the size of Alu region to the whole region of this intron (294 bp/531 bp=0.55). Therefore, the role of Alu sequence in the TLS-CHOP translocations, if any, may be limited to, for example, predisposing particular regions to rearrangements by forming loop structures. It has been previously suggested that such a mechanism may be operative in the BCR-ABL associated with chronic myelogenous leukemia (Cheng et al., 1989; Sowerby et al., 1993; Zhang et al., 1995) .
The next question is whether some other sequence motifs are directly involved in determining the site of breakpoints. In this respect, it is intriguing that the breakpoint sequence in two cases (KS407 and 302) showed a strong homology with the consensus binding site sequence of Translin (Aoki et al., 1995) . Translin was initially isolated as a protein binding to the translocation breakpoints sequence in hematopoietic malignancies Aoki et al., 1994) , and recently it was also demonstrated that Translin will bind to the translocation breakpoints in the PAX3-FKHR translocation in alveolar rhabdomyosarcomas (Chalk et al., 1997) . The degree of homology to known Translin-binding site in this study (88 and 92% identity in the two cases mentioned above) were even higher than those reported in PAX3-FKHR cases (62%), Supporting the hypothesis that these sequences may bind Translin in vivo, although no de®nite conclusions will be drawn without showing the evidence of binding.
Sequence determination of genomic fusion points revealed that there was no case of simple end-to-end translocation, and gain or loss of genetic material invariably accompanies the translocations. Recently a similar study on three cases of myxoid liposarcoma was reported, but the sequence analyses of CHOP-TLS fragments were not performed in detail (Panagopoulos et al., 1997) . Gain and loss of genetic material around the breakpoints has also been observed in translocation leading to the fusion of BCR and ABL in CML, and the molecular details in those cases are consistent with the hypothesis that a nuclease(s) involved in generating the translocation makes staggered cuts in the DNA strands followed by either deletion or DNA synthesis to ®ll the gap (Zhang et al., 1995) . In this study short direct repeats sequences were almost always found at the end of selected sequences. Similar features have been observed in intragenic deletions that aect the Rb tumor suppressor gene in human retinoblastoma (Canning and Dryja, 1989) , and`slipped mispairing' during DNA replication has been proposed to explain the mechanism of this phenomenon (Efstratiadis et al., 1980; Roth et al., 1985) . In some cases these repeats were present in the germline sequences, but in others they had apparently been created by joining of sequences that¯ank the rearrangement, suggesting that in some cases the deletion might occur after translocation. This mechanism may be relevant to experimental results obtained recently in experimental mouse plasmacytomas, in which the translocation of c-myc and IgHm locus was found to develop by two step process (Kovalchuk et al., 1997) .
The most striking result in this study may be the strong association of topoisomerase II site with translocation breakpoints. In one case (KS372) with a relatively large duplication (456 bp), were no topoisomerase II cleavage sites found near the breakpoints, however these were found to be close to poly (T) stretches, one of which was in Alu sequence. In all other cases with either deletions or duplications, sequence homologies (76 ± 100%) to topoisomerase II cleavage sites were always found at one end of deleted or duplicated fragments. Interestingly, the breakpoints of TLS gene in two of three cases reported on previously were close to the breakpoint of our case KS373 (within 20 based from either end of deletion ), and therefore also in the consensus topoisomerase II cleavage site (Panagopoulos et al., 1997). Topoisomerase II was known to create double-strand breaks to catalyse the unknotting or decatenation of DNA. The results of this study suggested the ability of topoisomerase II to function as an endonuclease may be important to the process of creating staggered double-standard cut ends. Because of the looseness of consensus sequences for topoisomerase II cleavage sites, in vivo binding experiments will be indispensable to ®rmly implicate the involvement of topoisomerase II as a key factor in the development of translocation.
Finally, we have found complex structural changes in two cases (Figure 7e and f) . It is interesting that two cases share a similar genetic alteration; insertion of sequences complementary to those found in the vicinity of breakpoints with an opposite direction. We were unable to ®nd this kind of complex mutation in published literatures and they may represent a new type of mutations.
Material and methods
Tumor samples and nucleic acid extraction
Nine myxoid liposarcomas and three round cell liposarcomas were analysed in this study. Patients were treated in Kyoto University Hospital or collaborating institutes and histological diagnosis of all cases was recon®rmed by one of us (YN). Tumor tissues were frozen immediately after surgical resection and stored at 7808C until nucleic acid extraction. High-molecular-weight DNA and total RNA was extracted from tissues as previously described (Sambrook et al., 1989) .
Southern blot analyses
7.5 mg of DNA was digested with appropriate restriction enzymes and separated by 0.7% agarose gel electrophoresis, transferred onto nylon membrane (Hybond-N, Amersham, Buckinghamshire, UK), and hybridized with [ 32 P] dCTP probes. Full length cDNA clones of CHOP and TLS gene were used as probes (Ron and Habener, 1992; Crozat et al., 1993) .
RT ± PCR
Three mg of total RNA was reverse-transcribed (RT) by Superscript II (Life Technologies, Inc., Rockville, MD, USA) using oligo d(T) primer, and 1/25 of the product was ampli®ed a sense primer in exon 4 of TLS, 294F (5'-CAGAGCTCCCAATCGTCTTACGG) and an antisense primer in exon 3 of CHOP gene, 176R (5'-GAGAAAGG-CAATGACTCAGCTGCC) by rTaq polymerase (TOYO-BO, Osaka, Japan). The PCR products were electrophoresed on 1% agarose gel, and ampli®ed fragments were recovered from the gel, puri®ed, and cloned into pCR2.1 vector (Invitrogen Co., Carlsbad, CA, USA). The sequences of cloned fragments were analysed by¯orescence-assisted sequencer (ALFexpress, Pharmacia, Uppsala, Sweden). A least two independent clones were sequenced.
Genomic long-distance PCR
The information of normal intron sequence is required to determine the precise location of breakpoints. Because the intron 5 and 7 sequence of TLS gene had been registered in Genbank, we determined the intron sequences of CHOP gene. Intron fragments were ampli®ed by LATaq polymerase (Takara Shuzo Co., Shiga, Japan) using sense primers in upstream exons and antisense primers in downstream exons. The primers used were as follows: for intron 1, 77F (sens, 5'-GCAGCGACAGAGCCAAAAT-CAGAGC) and 105R (antisense, 5'-CTGCTT-TCAGGTGTGGTGATGTAT); for intron 2, 119F (sense, 5'-ATACATCACCACACCTGAAAGCAG) and 176R (antisense). TLS-CHOP genomic fusion fragments encompassing the breakpoints were ampli®ed using one of following three sets of PCR primers; 294F and 105R, 431F (exon 5 of TLS/FUS, 5'-CAGCCAGCAGCCTAGC-TATG) and 105R, or 431F and 176R. To amplify CHOP-TLS fragments, 77F and 844R (exon 8 of TLS/FUS, 5'-ACGTGATCCTTGGTCCCGAG), or 77F and 652R (exon 6 of TLS/FUS, 5'-TCCACCACTCTGGTCTTGATTGC) were used. Ampli®ed fragments were cloned into pCR2.1 vector, and sequenced as same as RT ± PCR product. To sequence longer fragments, appropriate restriction enzymes were used to create several subclones, Sequence analysis were performed at least two clones in all cases. Most of primers used in this study were derived form previous reports (Panagopoulos et al., 1994 (Panagopoulos et al., , 1995 .
Sequence analyses with data base
The sequences around the breakpoint in each case were compared with following sequences which have been considered to be involved in the process of chromosomal rearrangements; Chi-like octamers (GC[A/T]GG[A/T]GG) (Krowczynska et al., 1990; Sowerby et al., 1993) , immunoglobulin heptamers (GATAGTG) (Cheng et al., 1989) , a-protein recognition sites (AAATATC and TTAATTC), topoisomerase II recognition sites (topoIIv, (Aoki et al., 1995) .
